The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective clinical study of precision oncology in solid tumors.
 
Davendra Sohal
Research Funding - Novartis (Inst)
 
Brian I. Rini
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Immatics (Inst); Millennium (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Alok A. Khorana
Honoraria - AngioDynamics; Daiichi Sankyo; Genentech; Johnson & Johnson; LEO Pharma; Sanofi
Consulting or Advisory Role - AngioDynamics; Daiichi Sankyo; Genentech; Johnson & Johnson; LEO Pharma; Sanofi
Research Funding - LEO Pharma
 
Robert Dreicer
Honoraria - Astellas Pharma
Consulting or Advisory Role - Astellas Pharma; BIND Biosciences; Dendreon; Medivation; Merck; Millennium; Roche
Research Funding - Progenics (Inst)
 
Jame Abraham
No Relationships to Disclose
 
Gary Procop
No Relationships to Disclose
 
Yogen Saunthararajah
No Relationships to Disclose
 
Nathan A. Pennell
Consulting or Advisory Role - Genentech
Research Funding - Astex Pharmaceuticals (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech (Inst); Newlink Genetics (Inst)
 
James Stevenson
Research Funding - Merck Sharp & Dohme (Inst); Verastem (Inst)
 
Robert James Pelley
No Relationships to Disclose
 
Bassam N. Estfan
No Relationships to Disclose
 
Dale Randall Shepard
No Relationships to Disclose
 
Pauline Funchain
No Relationships to Disclose
 
David J. Adelstein
Research Funding - GlaxoSmithKline (Inst); Sanofi (Inst)
 
Brian James Bolwell
No Relationships to Disclose